Oxurion NV (EBR:OXUR)

Belgium flag Belgium · Delayed Price · Currency is EUR
0.0070
+0.0004 (6.06%)
Jan 20, 2026, 5:09 PM CET
-96.96%
Market Cap413.15K
Revenue (ttm)2.00K
Net Income (ttm)1.96M
Shares Out62.60M
EPS (ttm)0.40
PE Ratio0.02
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,718,829
Average Volume470,679
Open0.0068
Previous Close0.0066
Day's Range0.0066 - 0.0076
52-Week Range0.0060 - 0.2595
Beta0.12
RSI39.38
Earnings DateApr 3, 2026

About Oxurion NV

Oxurion NV, a biopharmaceutical company, develops medicines to prevent blindness in Belgium. The company is developing ophthalmic treatments to preserve vision for patients with retinal disorders, including geographic atrophy and age-related macular degeneration. The company was formerly known as ThromboGenics NV and changed its name to Oxurion NV in September 2018. Oxurion NV was founded in 1991 and is headquartered in Leuven, Belgium. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1991
Employees 11
Stock Exchange Euronext Brussels
Ticker Symbol OXUR
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.